Diagnostic Accuracy Study for OWL-EVO1 As a Lung Cancer EVOC® Probe (Evolution Phase 2)

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(9 sites)

Czechia

Thomayer Hospital, Prague, Prague

Hungary

National Koranyi Institute for Pulmonology, Budapest, Budapest

Department of Pulmonology, University of Debrecen, Debrecen, Debrecen

United Kingdom

Royal Papworth Hospital NHS Foundation Trust, Cambridge, Cambridgeshire

Wythenshawe Hospital, Manchester, Greater Manchester

Glenfield Hospital, Leicester, Leicestershire

Barts Health NHS Trust, London, London

Imperial Centre for Translational and Experimental Medicine, Imperial College, London, London

Quadram Institute, Norwich, Norfolk